VIVOTIF
Identification of Vivotif
| No description |
Google image searchProduct monograph
Active ingredient
salmonella typhi ty21a live attenuated, 10000000000 CFU
DIN: 00885975
Dosage form(s): CAPSULE (ENTERIC-COATED)
Route(s) of administration: ORAL
Schedule: Schedule D
Company: BAVARIAN NORDIC AS
Date: 27-DEC-2023
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07A — BACTERIAL VACCINES (ATC, ATC/DDD)
- J07AP — Typhoid vaccines (ATC, ATC/DDD)
- J07AP01 — TYPHOID, ORAL, LIVE ATTENUATED (ATC/DDD)
Reference brand drug: Vivotif
